News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
DNAPrint Genomics Inc. Appoints Karen L. Surplus As New Chief Financial Officer
June 29, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
DNAPrint Genomics, Inc. (OTCBB: DNAG) today announced the appointment of Karen L. Surplus as the Company's new Chief Financial Officer.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Manufacturing
Lilly to Bring Nearly 2,500 Jobs to Virginia With $5B Manufacturing Plant
September 17, 2025
·
1 min read
·
Tristan Manalac
Startups
Ollin Emerges From Stealth With $100M To Develop Eye Disease Bispecifics
September 17, 2025
·
2 min read
·
Tristan Manalac
Artificial Intelligence
The Future of Pharma Is Predictive Care Powered by Consumers, AI: PwC
September 17, 2025
·
2 min read
·
Annalee Armstrong
Gene therapy
Doctors Still Prescribing Sarepta’s DMD Gene Therapy After Safety Concerns
September 16, 2025
·
3 min read
·
Annalee Armstrong
